Javier Montenegro will lead at CiQUS a new international project with Japan, Germany and Lithuania
We have been awarded with an !! The project TraffikGene will study the potential and the transference of our Gene Delivery Technology!
The research laboratories from the University of Santiago de Compostela (USC) will host an ambitious project financed with a total of about half a million euros involving agencies from four different countries. The project goal is to revolutionize the field of porous materials with nanometric control (
has highlighted the prices of the Royal Spanish Chemistry Society in its October Issue. We are so proud and thankful to be among these fantastic chemists! Congratulations to all my colleagues who I deeply admire and respect.
Download the note from .
Sabela Cebro from the platform has recently talked with us about the importance of academic industrial collaborations. For the interview, please click the and read more about our thoughts and discussion on knowledge transference from the University to the Industry.
Dr. Montenegro has been awarded with the of the Spanish Royal Society of Chemistry ()!!!
All credits go to the excellent and their great efforts and contributions. Many Thanks to all of you !! Check out in the following links some of the different press releases from this prestigious award!
Check out the great that Chemical Science and the Royal Society have made for our paper in CRISPR/Cas9 delivery mediated by hydrazone amphiphilic peptides!
A recent opinion article in the innovation guide of Galicia 2017.
Read about the reward of the I+D+i with capital I.
A nice from from V Televisión and La Voz de Galicia!
Don't miss and featuring in the video!!
Montenegro's peptide for Cas9 delivery and CRISPR genome edition!
Chemistry world has our recent paper in Cas9 delivery for CRISPR genome edition.
Excellent work and excellent article!
A nice in the Spanish newspaper La Razón. In the interview we comment on artificial cells and the importance of the cytoskeleton in the origin of life.
4/4/2017. From 3 min a really funny by the great in the M80 morning program.
30/04/2017. From minute 6 min the interview in V Televisión about the HFSP and our project regarding the creation of an artificial cytoskeleton.
Click for the youtube link. The interview starts at minute 6.
21/03/2017. Press article in the Faro de Vigo about the synthetic cell that we will approach within the framework of the HFSP network
21/03/2017. Excellent press article from our friend Raul Romar in La Voz de Galicia about the synthetic cell that we will approach within the framework of the HFSP network.
17/03/2017. We have been awarded with one of the . The project will approach the fabrication of a synthetic cytoskeleton!! Good luck to us all!!!!
30/01/2017. Alejandro has achieved the prestigious Marie Curie fellowship for his postdoctoral studies in the Montenegro group!
10/06/2016. A nice in El Correo Gallego of our article in penetrating polymers based in hydrazone dynamic bonds.
This paper was also highlighted in , the , and
05/02/2016. A beautiful in El Correo Gallego by Luis Pousa. In here we explain our project about dynamic penetrating peptides
27/01/2016. An interesting and funny in the program Efervesciencia na Radio Galega, conducted by Manuel Vicente and Einstein's Grandmother...!!
05/12/2015. The ERC starting grant in 2015 was in La Voz de Galicia with an excellent article of Raul Romar.
2/12/2015. The minister of Culture and Education of the Xunta de Galicia Román Rodriguez visited us at the CIQUS.
5/12/2015. The ERC Starting Grant in 2015 was in El Correo.
In the News!
12/2015. We have been awarded with an
15/11/2019. From min 30, a nice by Mamen Asencio in the RNE program Por tres razones.
We have been awarded with a project from the Instituto de Salud Carlos III to employ TraffikGene's amphiphiplic vehicles as vectors in the development of anti-COVID-19 mRNA vaccines
TraffikGene's technology to fight coronavirus pandemic
Universidad de Santiago de Compostela's crowdfunding program "Sumo Valor" will contribute with additional funding to our studies on efficient peptide vehicles for mRNA vaccination, which was originally selected by Instituto de Salud Carlos III in the fast response strategy of the Spanish government against COVID.
USC's program "Sumo Valor" provides additional support to TraffikGene's vaccination project
Exciting news about the recent clinical trials results of mRNA vaccines against COVID-19!
USC's Consello Social highlights the effort of its researchers in the fight against COVID with a special forum
Outreach activities in a new edition of Ciencia Singular - What do we do in the lab?
A new edition of the event took place the last weekend of November 2020, this year adapted to a virtual format but still with plenty of activities and meet-ups to bring the science developed at CiQUS closer to the general public.
Have a look at this amazing video in which we describe one of our research projects on the origin of life:
Our thoughts on gene therapy for the future of human health
We share our thoughts on how the different crysis that humanity has faced have boosted fundamental technological advances. The COVID pandemic has consolidated mRNA technology but, what will be next? Check put our perspective in this opinion article in La Voz de Galicia!
TraffikGene tech transfer project selected by Gain for Ignicia PoC funds
Our innovative delivery technology based on peptide amphiphiles has been awarded with new proof of concept funds to advance towards its marketing. TraffikGene advances into the funding phase of Ignicia Proof of Concept program, by the Axencia Galega de Innovación (Gain). This funding will help target key technological validations as well as carry out strategic and commercial activities to advance towards the incorporation of a spin-off company.
Our Nature Paper on Boron Clusters For Membrane Transport Got Wide Media Coverage
on 2022 Chemistry Nobel
Ligth for the of Peptides!
14/02/23 - The has funded with 2.5 M€ to finalise the transition to the industry of our technology for mRNA delivery. We couldn't be more motivated!!
The vicepresident of Xunta de Galicia and the Director of Innovation Agency (Gain) visit the TraffikGene Project
Crossing the membrane is a major challenge on the journey through the cell. Large biomolecules usually benefit from different transport strategies to overcome the lipid bilayer, so the design and synthesis of new carriers is key for the delivery of hydrophilic substances, such as pharmaceuticals, into the cell. Among these transporters, those using light as stimulus are particularly appealing due to their high precision, no chemical waste production and the possibility of remote application.
We are on the News!!
The European Innovation Council is backing up TraffikGene with one EIC-Transition Grants to take our mRNA delivery technology into Therapy!